Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.075 EUR
63.35 M EUR
1.13 B EUR
174.46 M
About Shandong Xinhua Pharmaceutical Company Limited Class A
Sector
Industry
CEO
Wen Hui Xu
Website
Headquarters
Zibo
Founded
1943
ISIN
CNE100000411
FIGI
BBG000CDQCM8
Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid. The company also sells pharmaceutical raw materials, preprations, antibiotic preparations, herbal medicine, biological products, medical appliances, chinese medicines and beauty products. Shandong Xinhua Pharmaceutical was founded in 1943 and is headquartered in Zibo, China.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Shandong Xinhua Pharmaceutical Company Limited Class H stocks are traded under the ticker XIN.
We've gathered analysts' opinions on Shandong Xinhua Pharmaceutical Company Limited Class H future price: according to them, XIN price has a max estimate of 1.32 EUR and a min estimate of 1.32 EUR. Watch XIN chart and read a more detailed Shandong Xinhua Pharmaceutical Company Limited Class H stock forecast: see what analysts think of Shandong Xinhua Pharmaceutical Company Limited Class H and suggest that you do with its stocks.
Yes, you can track Shandong Xinhua Pharmaceutical Company Limited Class H financials in yearly and quarterly reports right on TradingView.
Shandong Xinhua Pharmaceutical Company Limited Class H is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
XIN earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.02 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about Shandong Xinhua Pharmaceutical Company Limited Class H earnings.
XIN net income for the last quarter is 13.03 M EUR, while the quarter before that showed 14.23 M EUR of net income which accounts for −8.49% change. Track more Shandong Xinhua Pharmaceutical Company Limited Class H financial stats to get the full picture.
Shandong Xinhua Pharmaceutical Company Limited Class H dividend yield was 5.17% in 2024, and payout ratio reached 40.16%. The year before the numbers were 4.74% and 33.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Shandong Xinhua Pharmaceutical Company Limited Class H EBITDA is 118.99 M EUR, and current EBITDA margin is 12.57%. See more stats in Shandong Xinhua Pharmaceutical Company Limited Class H financial statements.
Like other stocks, XIN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Shandong Xinhua Pharmaceutical Company Limited Class H stock right from TradingView charts — choose your broker and connect to your account.